List of SBIR/STTR awards granted to TEGA THERAPEUTICS, INC.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to TEGA THERAPEUTICS, INC. in April, 2020 for $258,169.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS115099-01A1 | Phase I | 258,169 | April 15, 2020 | |||||||
A SBIR Phase I contract was awarded to TEGA THERAPEUTICS, INC. in August, 2019 for $225,254.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS112021-01A1 | Phase I | 225,254 | August 1, 2019 | |||||||
A SBIR Phase I contract was awarded to TEGA THERAPEUTICS, INC. in August, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS108853-01 | Phase I | 225,000 | August 1, 2018 | |||||||
A SBIR Phase II contract was awarded to TEGA THERAPEUTICS, INC. in December, 2020 for $999,948.0 USD from the National Science Foundation. | SBIR | 2026188 | Phase II | 999,948 | December 15, 2020 | |||||||
A SBIR Phase I contract was awarded to TEGA THERAPEUTICS, INC. in February, 2022 for $321,866.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL162135-01 | Phase I | 321,866 | February 5, 2022 | |||||||
A SBIR Phase I contract was awarded to TEGA THERAPEUTICS, INC. in September, 2015 for $237,138.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS089383-01A1 | Phase I | 237,138 | September 15, 2015 | |||||||
A SBIR Phase I contract was awarded to TEGA THERAPEUTICS, INC. in February, 2019 for $225,000.0 USD from the National Science Foundation. | SBIR | 1842736 | Phase I | 225,000 | February 1, 2019 | |||||||
A STTR Phase I contract was awarded to TEGA THERAPEUTICS, INC. in July, 2016 for $225,000.0 USD from the National Science Foundation. | STTR | 1622959 | Phase I | 225,000 | July 1, 2016 | |||||||
A SBIR Phase I contract was awarded to TEGA THERAPEUTICS, INC. in September, 2023 for $461,701.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS129414-01A1 | Phase I | 461,701 | September 15, 2023 |
